Puma Biotechnology Competitors and Similar CompaniesClear all
Puma Biotechnology's competitors and similar companies include ImmunoGen, Takeda and Oncopeptides.
 Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. |  ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. |  Takeda Takeda Pharmaceutical is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. | ||
Founding Date | Founding Date 2010 | Founding Date 1981 | Founding Date 1781 | Founding Date 2000 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Los Angeles, US HQ | Locations Waltham, US HQ | Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US | |
Employees | Employees 27214% decrease | Employees 277161% increase | Employees 49,281 | Employees 678% increase |
Valuation ($) | Valuation ($) 130 m | Valuation ($) 8.7 b | Valuation ($) 45.8 b | Valuation ($) 44.7 m |
Financial | ||||
Revenue (est.) | Revenue (est.) $235.6m (FY, 2023) | Revenue (est.) $108.8m (FY, 2022) | Revenue (est.) ¥4.3t (FY, 2024) | Revenue (est.) kr35.2m (FY, 2023) |
Cost of goods | Cost of goods $62.7m (FY, 2023) | Cost of goods $176k (FY, 2022) | Cost of goods ¥698.7b (FY, 2024) | Cost of goods (kr1.1m) (FY, 2023) |
Gross profit | Gross profit $173m (FY, 2023) | Gross profit $108.6m (FY, 2022) | Gross profit ¥3.6t (FY, 2024) | Gross profit kr42.6m (FY, 2023) |
Net income | Net income $21.6m (FY, 2023) | Net income ($222.9m) (FY, 2022) | Net income ¥144.2b (FY, 2024) | Net income (kr249.1m) (FY, 2023) |
Funding | ||||
Total funding raised | Total funding raised $ 172m | Total funding raised $ 56m | Total funding raised $ 57.8m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ImmunoGen
HQ
Waltham, US
Employees
277
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
View companyTakeda
HQ
Tokyo, JP
Employees
49,281
Takeda Pharmaceutical is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View company
Oncopeptides
HQ
Stockholm, SE
Employees
67↑ 8% increase
Oncopeptides is a clinical development pharmaceutical company.
View company